Valuation: Compumedics Limited

Market Cap 5.29Cr 3.79Cr 3.26Cr 3.06Cr 2.79Cr 5.27Cr 361.86Cr 36Cr 14Cr 182.55Cr 14Cr 14Cr 604.64Cr P/E 2026
255x
P/E 2027 * 12.6x
Enterprise Value 5.29Cr 3.79Cr 3.26Cr 3.06Cr 2.79Cr 5.27Cr 361.86Cr 36Cr 14Cr 182.55Cr 14Cr 14Cr 604.64Cr EV / Sales 2026
0.85x
EV / Sales 2027 * 0.7x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 7.55%
1 day-5.66%
1 week+8.70%
Current month+11.11%
1 month+4.17%
3 months-9.09%
6 months-21.88%
Current year-25.37%
1 week 0.22
Extreme 0.225
0.27
1 month 0.22
Extreme 0.215
0.27
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-5.66%+8.70%-12.28%+42.86% 3.79Cr
+0.89%+3.29%+29.73%+17.01% 23TCr
-0.28%+1.83%+4.42%-15.72% 15TCr
-0.38%-6.86%-21.90%+24.49% 13TCr
-3.39%-7.38%-54.72%-5.10% 7.23TCr
-0.10%-1.63%+11.70%+19.18% 5.24TCr
-1.11%-1.80%-16.89%-13.58% 5.16TCr
+0.20%-0.21%+31.09%+29.58% 4.37TCr
-0.07%-0.40%+39.86%+51.51% 4.07TCr
-0.38%+2.19%-17.35%+46.41% 3.41TCr
Average -1.03%+1.82%-0.63%+19.66% 8.1TCr
Weighted average by Cap. -0.25%-0.08%+3.55%+11.96%

Financials

2026 2027 *
Net sales 6.03Cr 4.32Cr 3.71Cr 3.48Cr 3.18Cr 6Cr 412.19Cr 41Cr 16Cr 207.95Cr 16Cr 16Cr 688.75Cr 7.56Cr 5.42Cr 4.65Cr 4.36Cr 3.99Cr 7.52Cr 516.78Cr 52Cr 20Cr 260.71Cr 20Cr 20Cr 863.5Cr
Net income 23L 16.48L 14.15L 13.28L 12.13L 22.89L 16Cr 1.57Cr 60.9L 7.93Cr 61.89L 60.55L 26Cr 60L 43L 36.91L 34.64L 31.64L 59.71L 41Cr 4.1Cr 1.59Cr 21Cr 1.61Cr 1.58Cr 69Cr
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
27/26/27 A$0.2500 -5.66% 41,320
25/26/25 A$0.2650 0.00% 3,70,702
24/26/24 A$0.2650 +12.77% 3,43,812
21/26/21 A$0.2350 +2.17% 25,718
20/26/20 A$0.2300 0.00% 37,326
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2650AUD
Average target price
0.6500AUD
Spread / Average Target
+145.28%

Annual profits - Rate of surprise